Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.
Santa Ana Bio has raised $125.0M in total funding. The most recent round was Series B. The last funding was announced in June 2024.
Santa Ana Bio's investors include TPG, Andreessen Horowitz, Versant Ventures, RTW Investments, Google Ventures.
Santa Ana Bio is headquartered in Alameda, United States.
Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.
Santa Ana Bio is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Santa Ana Bio — Funding & Investors." VCBacked, June 13, 2024, https://www.vcbacked.co/company/santa-ana-bio. Accessed September 22, 2026.
VCBacked. (2024). Santa Ana Bio — Funding & Investors. Retrieved September 22, 2026, from https://www.vcbacked.co/company/santa-ana-bio
{{cite web |title=Santa Ana Bio — Funding & Investors |url=https://www.vcbacked.co/company/santa-ana-bio |website=VCBacked |access-date=September 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated